UnknownPhase 2NCT03605199
Denosumab in Subjects With Giant Cell Rich Tumors of Bone
Studying Aneurysmal bone cyst
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leiden University Medical Center
- Principal Investigator
- AJ Gelderblom, ProfLeiden University Medical Center
- Intervention
- Denosumab(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2023
Study locations (3)
- Centre Léon Bérard, Lyon, France
- Istituto Ortopedico Rizzoli, Bologna, Italy
- Leiden University Medical Center, Leiden, Netherlands
Collaborators
Amgen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03605199 on ClinicalTrials.gov